FDA authorizes sample pooling for SalivaDirect PCR COVID-19 test
Weighing risks and benefits of COVID-19 vaccination in children
2 November 2021Study identifies specific drugs that can prevent disease-causing activity of key immune cells
2 November 2021FDA authorizes sample pooling for SalivaDirect PCR COVID-19 test
The U.S. Food and Drug Administration (FDA) has authorized the SalivaDirect PCR COVID-19 test created by the Yale School of Public Health for use with pooled saliva samples.
